TCL Archive Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year May 23, 1975
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive NCI to Implement Plan For Stepped Up Patient Accrual Despite Reservations OF Group Chairmen December 4, 1987
TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008
TCL Archive In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei May 22, 1992
